bupropion
- Product NDC
- 68001-264
- 11-digit product format
- 680010264
- Labeler code
- 68001
- Product ID
- 68001-264_688cfb04-0f6b-4e42-be01-b0e4c33b1402
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA201567
- Marketing category
- ANDA
- Marketing start
- 2014-10-03
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-264-03 | 68001026403 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-264-03) | 2014-10-03 | 0000-00-00 | No | No | Current |
| 68001-264-04 | 68001026404 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-264-04) | 2014-10-03 | 0000-00-00 | No | No | Current |
| 68001-264-05 | 68001026405 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-264-05) | 2014-10-03 | 0000-00-00 | No | No | Current |